Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150
CANO.WS
CANO.WS was delisted on the 9th of November, 2023.
27 hedge funds and large institutions have $3.18M invested in Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 in 2022 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 4 increasing their positions, 7 reducing their positions, and 9 closing their positions.
10% less funds holding
Funds holding: 30 → 27 (-3)
33% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 9
43% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 7
93% less capital invested
Capital invested by funds: $45.9M → $3.18M (-$42.7M)
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ZA
Zazove Associates
Incline Village,
Nevada
|
+$3.95M |
| 2 |
CAC
Cowen and Company
New York
|
+$675K |
| 3 |
JAIC
Josh Arnold Investment Consultant
Edina,
Minnesota
|
+$444K |
| 4 |
DKCM
Davidson Kempner Capital Management
New York
|
+$422K |
| 5 |
Walleye Capital
New York
|
+$139K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LP
LMR Partners
London,
United Kingdom
|
-$9.83M |
| 2 |
UFM
Ursa Fund Management
Danville,
California
|
-$7.4M |
| 3 |
DCM
Difesa Capital Management
New York
|
-$1.14M |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$918K |
| 5 |
ICM
Ionic Capital Management
New York
|
-$887K |
CANO.WS Hedge Fund Activity: Q4 2022 in Review
27 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 (CANO.WS) for Q4 2022, worth a combined $3.18M — down 93% from $45.9M a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of CANO.WS and 6 opened new positions — a net loss of 3 holders — while 7 trimmed existing stakes and 4 added.
The largest buyer was Zazove Associates, adding an estimated $3.95M. The largest seller was LMR Partners, exiting entirely with an estimated $9.83M sold.
- 27 institutional investors held Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 (CANO.WS) as of Q4 2022, down from 30 in Q3 2022.
- Funds reported $3.18M of Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 stock for Q4 2022, down 93% quarter-over-quarter.
- 6 funds opened new Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 positions in Q4 2022 and 9 closed out, a net change of -3 holders.
- The largest Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 buyer in Q4 2022 was Zazove Associates, an estimated $3.95M added.
- The largest Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 seller in Q4 2022 was LMR Partners, an estimated $9.83M sold.
Based on aggregated 13F filings for Q4 2022.